Conrad Wai, CEO, Counterpart Health at CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV), sold 220,426 shares at $3.99 ($879K) on 2026-05-28, disclosed to the SEC on 2026-05-28.
Scheduled sale ($879k) by CEO, Counterpart Health under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| CLOV | SELL | 2025-07-24 | $996K | — | Filing → |
| CLOV | SELL | 2025-07-10 | $50K | — | Filing → |